HDAC2 and TXNL1 Distinguish Aneuploid from Diploid Colorectal Cancers

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2011 Feb 4

PMID 21290163

Citations 12

Authors

Timo Gemoll

Uwe J Roblick

Silke Szymczak

Till Braunschweig

Susanne Becker

Bernd-Wolfgang Igl

Hans-Peter Bruch

Andreas Ziegler

Ulf Hellman

Michael J Difilippantonio

Thomas Ried

Hans Jornvall

Gert Auer

Jens K Habermann

Affiliations

Soon will be listed here.

Abstract

DNA aneuploidy has been identified as a prognostic factor for epithelial malignancies. Further understanding of the translation of DNA aneuploidy into protein expression will help to define novel biomarkers to improve therapies and prognosis. DNA ploidy was assessed by image cytometry. Comparison of gel-electrophoresis-based protein expression patterns of three diploid and four aneuploid colorectal cancer cell lines detected 64 ploidy-associated proteins. Proteins were identified by mass spectrometry and subjected to Ingenuity Pathway Analysis resulting in two overlapping high-ranked networks maintaining Cellular Assembly and Organization, Cell Cycle, and Cellular Growth and Proliferation. CAPZA1, TXNL1, and HDAC2 were significantly validated by Western blotting in cell lines and the latter two showed expression differences also in clinical samples using a tissue microarray of normal mucosa (n=19), diploid (n=31), and aneuploid (n=47) carcinomas. The results suggest that distinct protein expression patterns, affecting TXNL1 and HDAC2, distinguish aneuploid with poor prognosis from diploid colorectal cancers.

Citing Articles

Predictive value analysis of the interaction network of Tks4 scaffold protein in colon cancer.

Tilajka A, Kurilla A, Laszlo L, Lovrics A, Novak J, Takacs T Front Mol Biosci. 2024; 11:1414805.

PMID: 39234565 PMC: 11371697. DOI: 10.3389/fmolb.2024.1414805.

The role of TXNL1 in disease: treatment strategies for cancer and diseases with oxidative stress.

Zhao J, Qi T Mol Biol Rep. 2021; 48(3):2929-2934.

PMID: 33660093 DOI: 10.1007/s11033-021-06241-z.

GPR126 regulates colorectal cancer cell proliferation by mediating HDAC2 and GLI2 expression.

Cui H, Yu W, Yu M, Luo Y, Yang M, Cong R Cancer Sci. 2021; 112(5):1798-1810.

PMID: 33629464 PMC: 8088945. DOI: 10.1111/cas.14868.

The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.

Tang W, Zhou W, Xiang L, Wu X, Zhang P, Wang J Nat Commun. 2019; 10(1):663.

PMID: 30737378 PMC: 6368584. DOI: 10.1038/s41467-018-08225-3.

Trichostatin A preferentially reverses the upregulation of gene-expression levels induced by gain of chromosome 7 in colorectal cancer cell lines.

Buishand F, Cardin E, Hu Y, Ried T Genes Chromosomes Cancer. 2017; 57(1):35-41.

PMID: 28940826 PMC: 8058626. DOI: 10.1002/gcc.22505.

References

Powis G, Mustacich D, Coon A . The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med. 2000; 29(3-4):312-22. DOI: 10.1016/s0891-5849(00)00313-0. View

Ashktorab H, Belgrave K, Hosseinkhah F, Brim H, Nouraie M, Takkikto M . Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma. Dig Dis Sci. 2008; 54(10):2109-17. PMC: 2737733. DOI: 10.1007/s10620-008-0601-7. View

Melcher R, Koehler S, Steinlein C, Schmid M, Mueller C, Luehrs H . Spectral karyotype analysis of colon cancer cell lines of the tumor suppressor and mutator pathway. Cytogenet Genome Res. 2003; 98(1):22-8. DOI: 10.1159/000068544. View

Duval A, Hamelin R . Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 2002; 62(9):2447-54. View

Jefford C, Irminger-Finger I . Mechanisms of chromosome instability in cancers. Crit Rev Oncol Hematol. 2006; 59(1):1-14. DOI: 10.1016/j.critrevonc.2006.02.005. View

Manandhar G, Miranda-Vizuete A, Pedrajas J, Krause W, Zimmerman S, Sutovsky M . Peroxiredoxin 2 and peroxidase enzymatic activity of mammalian spermatozoa. Biol Reprod. 2009; 80(6):1168-77. DOI: 10.1095/biolreprod.108.071738. View

Harms K, Chen X . Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity. Cancer Res. 2007; 67(7):3145-52. DOI: 10.1158/0008-5472.CAN-06-4397. View

Diaz-Uriarte R, de Andres S . Gene selection and classification of microarray data using random forest. BMC Bioinformatics. 2006; 7:3. PMC: 1363357. DOI: 10.1186/1471-2105-7-3. View

Bomme L, Bardi G, Pandis N, Fenger C, Kronborg O, Heim S . Clonal karyotypic abnormalities in colorectal adenomas: clues to the early genetic events in the adenoma-carcinoma sequence. Genes Chromosomes Cancer. 1994; 10(3):190-6. DOI: 10.1002/gcc.2870100307. View

10.

Habermann J, Upender M, Roblick U, Kruger S, Freitag S, Blegen H . Pronounced chromosomal instability and multiple gene amplifications characterize ulcerative colitis-associated colorectal carcinomas. Cancer Genet Cytogenet. 2003; 147(1):9-17. DOI: 10.1016/s0165-4608(03)00219-x. View

11.

Carrette O, Burkhard P, Sanchez J, Hochstrasser D . State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics research. Nat Protoc. 2007; 1(2):812-23. DOI: 10.1038/nprot.2006.104. View

12.

Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K . Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer. 1996; 15(4):234-45. DOI: 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2. View

13.

Song J, Noh J, Lee J, Eun J, Ahn Y, Kim S . Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS. 2005; 113(4):264-8. DOI: 10.1111/j.1600-0463.2005.apm_04.x. View

14.

Hellman U . Sample preparation by SDS/PAGE and in-gel digestion. EXS. 2000; 88:43-54. DOI: 10.1007/978-3-0348-8458-7_3. View

15.

Munster P, Marchion D, Thomas S, Egorin M, Minton S, Springett G . Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. Br J Cancer. 2009; 101(7):1044-50. PMC: 2768109. DOI: 10.1038/sj.bjc.6605293. View

16.

Weichert W, Roske A, Niesporek S, Noske A, Buckendahl A, Dietel M . Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res. 2008; 14(6):1669-77. DOI: 10.1158/1078-0432.CCR-07-0990. View

17.

Bland J, Altman D . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. View

18.

Jimenez A, Pelto-Huikko M, Gustafsson J, Miranda-Vizuete A . Characterization of human thioredoxin-like-1: potential involvement in the cellular response against glucose deprivation. FEBS Lett. 2006; 580(3):960-7. DOI: 10.1016/j.febslet.2006.01.025. View

19.

Yamamoto T, Matsumoto K, Iriyama K . Prognostic significance of the DNA index in a colorectal cancer. Surg Today. 1998; 28(8):792-6. DOI: 10.1007/s005950050228. View

20.

Chang H, Chiang C, Hung H, Lin C, Deng Y, Yen-Ping Kuo M . Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol. 2008; 45(7):610-4. DOI: 10.1016/j.oraloncology.2008.08.011. View